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Table 1
RPE65 Gene Mutations in Patients in the LCA2 Group
Family Number
and Location







Exon 9 G1043A C330Y Homozygous 
2:
Intron 1 G/A 655G/A Homozygous 
3:
Exon 3 C244T Q64X Homozygous 
4:
Intron 8 G/A 9121G/A 
5:
Exon 12 C1355T A434V 
6:
Exon 10 DelA 1114DelA 
Exon 7 C754T R234X 
7:
Exon 10 C1141A P363T 
Exon 13 T1472A V473N 
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Different Functional Outcome of RetGC1 and RPE65
Gene Mutations in Leber Congenital Amaurosis
To the Editor:
Leber congenital amaurosis (LCA) has the earliest age
at onset and is the most severe of the inherited retinal
dystrophies (Leber 1869). It accounts for 5% of all
retinal dystrophies and probably accounts for a higher
percentage in countries with a high rate of consanguinity
(Foxman et al. 1985; Kaplan et al. 1990). LCA is an
autosomal recessive condition, distinct from all other
retinopathies in that the visual disorder is diagnosed at
birth or during the first months of life in an infant with
total blindness or greatly impaired vision, normal fun-
dus, and extinguished electroretinogram (ERG; Fran-
ceschetti and Dieterle 1954). Although major visual im-
pairment is easily recognizable at birth, LCA was largely
underdiagnosed until ERG performed on infants showed
that the condition is not uncommon. A certain degree
of clinical heterogeneity has long been recognized in
LCA (Merin 1991; Trabousli et al. 1995); however, ge-
netic heterogeneity of LCA has been suspected since the
report by Waardenburg et al. (1963) of normal-sighted
children born to parents who were both affected with
LCA.
We mapped the first LCA gene (LCA1) on the short
arm of chromosome 17p13.1 and confirmed the genetic
heterogeneity of the disease (Camuzat et al. 1995, 1996).
Perrault et al. (1996) ascribed LCA1 to mutations in the
photoreceptor-specific guanylate cyclase gene, RetGC1,
which catalyses the conversion of guanine triphosphate
to cyclic guanine monophosphate (cGMP) in the retina.
To date, a total of 18 different mutations have been
found in 20 unrelated families originating from various
countries across the world, especially the Mediterranean
region. The observation of missense and frameshift
RetGC1 mutations suggests that the cGMP production
in photoreceptor cells is markedly reduced or abolished
in LCA (Perrault et al. 1996). As a consequence, the
excitation process of rod and cone photoreceptorswould
be markedly impaired because of constant closure of
cGMP-gated cation channels, with hyperpolarization of
Figure 1 Segregation of RPE65 mutations in seven families in group LCA2. An “m” denotes a mutant allele; a plus sign () denotes a
wild-type allele; and a question mark (?) denotes a second mutation not yet identified.
Table 2
Phenotypic Differences in the LCA1 and LCA2 Groups
Characteristic LCA1 LCA2
Disease gene RetGC1 RPE65
Age at onset Birth Birth
Mode of onset Inability to follow light or items Inability to follow light or items
Roving eye movements Roving eye movements
Pendular nystagmus Pendular nystagmus
Normal fundus at birth followed by salt-and-
pepper aspect of the retina and typical as-
pect of RPa
Normal fundus at birth followed by salt-and-
pepper aspect of the retina and typical as-
pect of RPa
Ophthalmologic examination Nonrecordable ERG (never done before 3 mo) Nonrecordable ERG (never done before 3 mo)
Severe hyperopia Moderate or no hyperopia, sometimes low
myopia
Nonrecordable visual field Concentric reduction of visual field
Outcome Nonevolutive congenital blindness Transient improvement: ability to follow light
or large items, especially during daytime
Severe photophobia Night blindness
Visual acuity Light perception or finger counting 6/606/30
a RP  retinitis pigmentosa.
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the plasma membrane. Indeed, the cGMP concentration
in photoreceptor cells could not be restored to the dark
level, leading to a situation equivalent to constant light
exposure during photoreceptor development. This hy-
pothesis is consistent with the markedly impaired vision
noted in the first days of life.
Another gene, the retinal pigment epithelium (RPE)–
specific gene (RPE65), mapped to chromosome 1p31,
has been found to carry deleterious mutations in patients
with LCA (Marlhens et al. 1997; Morimura et al. 1998)
and autosomal recessive childhood-onset severe retinal
dystrophies (CSRD; Gu et al. 1997). RPE65 is believed
to act as the isomerase catalyzing the conversion of all-
trans-retinyl-ester to 11-cis-retinol in the RPE, an essen-
tial step in the metabolism of vitamin A, the precursor
of rhodopsin (Hamel et al. 1998). Thus, in contrast with
RetGC1 mutations, RPE65 mutations would decrease
the rhodopsin production, leading to a situation equiv-
alent to a retina kept in a constant dark state. Hence,
these cases of Leber amaurosis would represent the ex-
treme end of a spectrum of diseases classified as retinal
dystrophies (Morimura et al. 1998).
We have studied a series of 15 multiplex families with
LCA unlinked to chromosome 17p13.1, using poly-
morphic markers flanking the RPE65 locus (Gu et al.
1997). Combination of all findings for the 15 families
gave no significant LOD scores (data not shown, avail-
able on request), but 8 of 15 families were consistent
with linkage to 1p31. For this reason, we did a search
for RPE65 gene mutations by SSCP analysis and direct
sequencing in the eight families with linkage to 1p31,
as well as in sporadic cases (Marlhens et al. 1997).
RPE65 gene mutations were identified in five of eight
multiplex families with linkage to 1p31 and in two fam-
ilies with sporadic cases (fig. 1). All missense mutations
involved conserved amino acids and were absent in 50
healthy controls. Three patients born to consanguineous
parents carried homozygous RPE65 gene mutations (ta-
ble 1).
Because there are different pathophysiologic pathways
involved in the disease, the patients with LCA were split
into two groups, LCA1 and LCA2, on the basis of their
underlying mutations, and their clinical histories were
revisited. No difference in age or mode of onset was
observed between the RetGC1 (LCA1) and the RPE65
(LCA2) groups. Indeed, symptoms of LCA always began
at birth or in the first few weeks of life and were char-
acterized by roving eye movements and inability to fol-
low light or objects. The results of fundus examination
in the two groups were quite similar as well. There was
an initially normal fundus, which gradually displayed a
salt-and-pepper appearance with a reduction in blood-
vessel diameter and often the typical appearance of ret-
initis pigmentosa. Moreover, the ERG response was to-
tally extinguished, even at age 3 mo.
Despite the similarities listed above, outcome of the
disease was different for each of the groups. Indeed, in
the patients harboring RetGC1 mutations, no visual im-
provement was observed, the pendular nystagmus re-
mained unchanged, and visual acuity was reduced to
light perception or ability to count fingers held in the
visual field. In addition, the patients complained of se-
vere photophobia and usually preferred half light. A sig-
nificant hyperopia was observed consistently, and the
visual field was not recordable because of profound loss
of visual acuity (table 2). However, in the patients har-
boring RPE65 mutations, transient improvement was
regularly noted by the parents. Young children became
able to follow light or objects, especially during daytime.
They complained of night blindness and usually pre-
ferred bright light. Visual acuity reached 6/60–6/30,mild
or no hyperopia was observed, and mild myopia occured
occasionally. Finally, the visual field in this group was
usually recordable and frequently displayed a peripheric
concentric reduction (table 2).
In conclusion, the present study supports variable
functional outcome in LCA, depending on the disease-
causing gene. RetGC1 gene mutations are responsible
for a congenital cone-rod dystrophy with dramatic and
invariable cone dysfunction. RPE65 gene mutations are
responsible for a severe yet progressive rod-cone dystro-
phy, still different from the congenital stationary blind-
ness caused by RetGC1 gene mutations. These discrep-
ancies are of particular importance for anticipating the
final outcome in a blind infant and for directing further
genetic studies in older patients.
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The APC I1307K Allele and BRCA-Associated Ovarian
Cancer Risk
To the Editor:
Most ovarian cancers attributable to autosomal domi-
nant genetic predisposition (∼10% of all cases) are as-
sociated with germ-line mutations in the BRCA1 or
BRCA2 genes (reviewed in Boyd 1998). Estimates of the
lifetime probability of developing ovarian cancer in as-
sociation with a BRCA mutation have a range of
16%–63% (Easton et al. 1995; Struewing et al. 1997;
Ford et al. 1998). This large variation in penetrance is
widely presumed to reflect the effects of various hor-
monal, environmental, and genetic modifiers, but few
such modifying factors have been identified. The use of
oral contraceptives was recently shown to substantially
reduce the risk of ovarian cancer in women with BRCA
mutations (Narod et al. 1998), yet it has been suggested
that bearing more offspring increases ovarian cancer risk
in BRCA1 carriers (Narod et al. 1995). The only genetic
modifier of BRCA penetrance yet shown is the HRAS1
locus, rare alleles of which are associated with an in-
creased risk of ovarian cancer in BRCA1 carriers (Phelan
et al. 1996).
The APC I1307K allele is a plausible candidate mod-
ifier of BRCA penetrance. First identified as a founder
mutation occurring in ∼6% of the Ashkenazi Jewish
population, the allele is present in a significantly higher
proportion of Jewish colorectal cancer patients and in
those with a family history of colorectal cancer (Laken
et al. 1997). The mechanism through which this allele
contributes to the development of colorectal cancer ap-
pears to involve the creation of a small hypermutable
region that undergoes somatic frameshift alterations
leading to APC inactivation and the initiation of tu-
morigenesis (Laken et al. 1997; Gryfe et al. 1998). Con-
sistent with this molecular genetic scenario are the well-
established roles of somatic APC mutations in the
initiation of sporadic colorectal cancer and germ-line
APC mutations in predisposition to familial adenoma-
tous polyposis (Kinzler and Vogelstein 1996).
Attempts to confirm and extend the original obser-
vation of APC I1307K-associated cancer risk in Ash-
kenazi Jews have produced inconsistent findings. Results
from one follow-up study implied that the APC I1307K
mutation alone does not significantly increase the risk
of colorectal cancer (Petrukhin et al. 1997). Recent data
from a large community-based study of Ashkenazi Jews
indicated that APC I1307K confers a modest but sig-
nificant risk of cancer in general but that odds ratios for
any particular cancer are not increased to statistically
significant levels (Woodage et al. 1998). Remarkably,
however, there is an apparent synergy between APC
I1307K and a mutant BRCA allele in relation to breast
cancer risk (Redston et al. 1998). Taken together, these
data suggest that APC I1307K may function as a low-
penetrance modifier of cancer risk in association with
high-penetrance cancer-predisposition alleles such as
BRCA1 or BRCA2. Thus, even though APC I1307K
alone does not appear to confer a substantial risk of
